Finch Therapeutics Group Probability of Future Pink Sheet Price Finishing Under 0.42
| FNCHDelisted Stock | USD 8.51 0.19 2.18% |
Finch |
Finch Therapeutics Target Price Odds to finish below 0.42
The tendency of Finch Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.42 or more in 90 days |
| 8.51 | 90 days | 0.42 | near 1 |
Based on a normal probability distribution, the odds of Finch Therapeutics to drop to $ 0.42 or more in 90 days from now is near 1 (This Finch Therapeutics Group probability density function shows the probability of Finch Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Finch Therapeutics price to stay between $ 0.42 and its current price of $8.51 at the end of the 90-day period is about 23.46 .
Given the investment horizon of 90 days Finch Therapeutics Group has a beta of -0.88. This usually indicates Additionally Finch Therapeutics Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Finch Therapeutics Price Density |
| Price |
Predictive Modules for Finch Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Finch Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Finch Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Finch Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Finch Therapeutics is not an exception. The market had few large corrections towards the Finch Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Finch Therapeutics Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Finch Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.1 | |
β | Beta against Dow Jones | -0.88 | |
σ | Overall volatility | 1.77 | |
Ir | Information ratio | -0.05 |
Finch Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Finch Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Finch Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Finch Therapeutics is not yet fully synchronised with the market data | |
| Finch Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 107 K. Net Loss for the year was (74.75 M) with loss before overhead, payroll, taxes, and interest of (57.03 M). | |
| Finch Therapeutics Group currently holds about 104.67 M in cash with (31.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.19. | |
| Roughly 53.0% of the company shares are held by company insiders |
Finch Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Finch Pink Sheet often depends not only on the future outlook of the current and potential Finch Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Finch Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 M | |
| Cash And Short Term Investments | 25.1 M |
Finch Therapeutics Technical Analysis
Finch Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Finch Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Finch Therapeutics Group. In general, you should focus on analyzing Finch Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Finch Therapeutics Predictive Forecast Models
Finch Therapeutics' time-series forecasting models is one of many Finch Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Finch Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Finch Therapeutics
Checking the ongoing alerts about Finch Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Finch Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Finch Therapeutics is not yet fully synchronised with the market data | |
| Finch Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 107 K. Net Loss for the year was (74.75 M) with loss before overhead, payroll, taxes, and interest of (57.03 M). | |
| Finch Therapeutics Group currently holds about 104.67 M in cash with (31.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.19. | |
| Roughly 53.0% of the company shares are held by company insiders |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Finch Pink Sheet
If you are still planning to invest in Finch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Finch Therapeutics' history and understand the potential risks before investing.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |